SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-035165
Filing Date
2021-05-24
Accepted
2021-05-24 08:39:46
Documents
1
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4621
  Complete submission text file 0001209191-21-035165.txt   6029
Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BLVD. BRISBANE CA 94005
Business Address
Nolan Sean P. (Reporting) CIK: 0001569926 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39536 | Film No.: 21951328

Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences